PEPCID

This brand name is authorized in United States. It is also authorized in Canada, Finland, Ireland, Spain.

Active ingredients

The drug PEPCID contains one active pharmaceutical ingredient (API):

1	Famotidine UNII 5QZO15J2Z8 - FAMOTIDINE
	Famotidine is a potent competitive H2-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations.
	Read more about Famotidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PEPCID Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
PEPCID Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)
PEPCID AC Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BA03	Famotidine	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists
Discover more medicines within A02BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02185938
ES	Centro de información online de medicamentos de la AEMPS	62090
FI	Lääkealan turvallisuus- ja kehittämiskeskus	082818, 082909, 572007
US	FDA, National Drug Code	0187-4420, 0187-4440, 65649-211